Vaccine News and Research

Latest Vaccine News and Research

Pneumonia frequency and severity found to be lower in patients with full COVID-19 vaccination

Pneumonia frequency and severity found to be lower in patients with full COVID-19 vaccination

1 Jun 2022
Genetically modified herpes virus can be used in the fight against cancer

Genetically modified herpes virus can be used in the fight against cancer

1 Jun 2022
Midwifery education in Bangladesh has greatly improved women’s access to safe childbirth, studies show

Midwifery education in Bangladesh has greatly improved women’s access to safe childbirth, studies show

1 Jun 2022
COVID-19 infections during the Omicron wave in unvaccinated US adults

COVID-19 infections during the Omicron wave in unvaccinated US adults

1 Jun 2022
Infection rates and immunological responses to SARS-CoV-2 infection among migrant workers

Infection rates and immunological responses to SARS-CoV-2 infection among migrant workers

1 Jun 2022
Researchers identify molecular characteristics linked to increased likelihood of post-vaccination fatigue

Researchers identify molecular characteristics linked to increased likelihood of post-vaccination fatigue

31 May 2022
COVID-19 pandemic increased the number of cancer-related mortality in the U.S., study shows

COVID-19 pandemic increased the number of cancer-related mortality in the U.S., study shows

31 May 2022
Loneliness and social stress can have negative impact on COVID-19 vaccine antibody response, study reveals

Loneliness and social stress can have negative impact on COVID-19 vaccine antibody response, study reveals

31 May 2022
Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

31 May 2022
Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

31 May 2022
The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

31 May 2022
The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

31 May 2022
Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

31 May 2022
The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

31 May 2022
Politics and pandemic fatigue doom California’s covid vaccine mandates

Politics and pandemic fatigue doom California’s covid vaccine mandates

31 May 2022
HIV research enables knowledge transfer for improved COVID-19 response

HIV research enables knowledge transfer for improved COVID-19 response

31 May 2022
New Director of Science, Research and Evidence will help steer research across health and social care

New Director of Science, Research and Evidence will help steer research across health and social care

30 May 2022
Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

30 May 2022
Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

30 May 2022
Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

30 May 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback